NewsSee below for Podcasts
May 09, 2013
Annual Gala Raises Over $440,000 to Fund New Treatment Options for Kids
Fashion industry and Hollywood heavyweights joined Solving Kids’ Cancer co-founders Scott Kennedy, John and Catherine London on May 7, at 583 Park and raised over $440,000 that will fund a clinical research trial to identify new treatment options for the deadliest of childhood cancers
April 03, 2013
Researchers to develop next generation immunotherapy for children with deadly solid tumors
Recently, research using adoptive T-cell immunotherapy in blood cancers have shown success, most notably in the case of a seven-year-old girl whose leukemia went into remission using altered T-cells and a disabled HIV virus. Now, two of the pediatric cancer scientists involved in the T-cell/HIV study will develop a new experimental cancer immunotherapy treatment option for children with high-risk solid tumors based on the same novel approach that uses a patient's own T-cells to attack tumor cells.
February 27, 2013
SKC Introduces New International Initiative
Solving Kids’ Cancer, along with U.K.-based charities Neuroblastoma Alliance UK, J-A-C-K, and other European organizations, have aligned forces to improve access to clinical trials for children with high-risk neuroblastoma in North America, the U.K. and Europe. The new initiative, the International Neuroblastoma Research Collaborative (INBRC), mandates a collaboration of international cancer centers, offering a grant award of up to $500,000 (U.S.).
January 29, 2013
SKC-funded Vaccine Research Leads to Complete Remission in Child With Relapsed Neuroblastoma
One year after his last treatment, a six-year-old boy with recurrent neuroblastoma is in complete remission for his high-risk metastatic cancer. Doctors reported this case study in the January 2013 issue of Pediatrics, the journal of the American Academy of Pediatrics, which was funded in part by a joint grant from the Andrew McDonough B+ Foundation, Pierce Phillips Charity and Solving Kids’ Cancer.
December 28, 2012
SKC has a New Home!
After much searching Solving Kids Cancer is very pleased to announce the new, permanent location of our offices. As of January 1, 2013 we will be located at 1 East 53rd Street, 5th Floor, New York, NY 10022. Our phone number will remain 212-588-6624.
We are very happy to be part of a historic NYC building which once housed the William S. Paley Museum of Broadcasting. In 1991 the museum relocated to 25 West 52nd Street. Mr. Paley, long advocate for non-profit organizations, kept the East 53rd building and made it available exclusively to non-profits.
December 10, 2012
Happy Holidays
We wish all our friends, donors, colleagues and partners a very joyous holiday season.
Your support means the world to us and to the families we serve.
November 16, 2011
Our Newest Therapeutic Development Study Focuses on the Promise of a Cancer Vaccine
Solving Kids' Cancer has embarked on a new clinical study offering a novel vaccine therapy in combination with a targeted agent for children with relapsed high-risk neuroblastoma. The Andrew McDonough B+ Foundation has partnered with SKC to fund this trial with a grant of $145,000, which constitutes 70% of the trial cost.
September 22, 2011
Positive Data on Viral Agent JX-594 in Nature Further Bolsters SKC-Initiated Research Project
The recent publication of positive data on Jennerex JX-594 for adult cancer clinical trials in the journal Nature has served to further validate SKC’s early championing of this novel experimental agent. Three years ago, Solving Kids’ Cancer first coordinated a strategic partnership between Jennerex and the two hospital centers to begin conducting JX-594 pediatric cancer clinical trials for children suffering from solid tumors. SKC subsequently launched the research projects by providing 100% of the funding. . The first phase of the trials started last year and are currently underway.
March 01, 2011
SKC on NBC News and in the Wall Street Journal
The founders of Solving Kids' Cancer share some personal stories and describe the charity's efforts to improve survival for children by expanding the menu of novel treatment options on NBC News and the Wall Street Journal
January 25, 2011
Webinar Archive - for Families & Researchers - Oncolytic Virotherapy for Pediatric Cancer
PLEASE CLICK "READ MORE" BELOW TO WATCH/LISTEN TO A REPLAY OF THE WEBINAR: In 2011, there will be 5 clinical trials for pediatric solid tumors using oncolytic viruses. On January 25, SKC held a live discussion that included all of the Principal Investigators describing the studies and a general overview of this new and promising therapeutic option for pediatric cancer. Click the link below to watch/listen to the webinar archive.
October 12, 2010
SKC's Early Support Pays Off as FDA Invests in Novel Treatment
In December 2009, SKC supported a novel immunotherapy trial for children using the HSV virus. Now the FDA has awarded a grant to the researchers at Cincinnati Children's Hospital to treat even more children. Read the article:
September 13, 2010
SKC Partners with BGC in 6th Annual Charity Day
BGC Partners, one of the world's leading brokers, raised in excess of $10 million for charity on its sixth annual Charity Day held on Monday, September 13. This year Solving Kids' Cancer was one of the 18 designated recipient charities in the US.
August 22, 2010
New Twist on Drug Screening To Treat Common Childhood Cancer
Scientists, supported by funding from Solving Kids' Cancer, have developed a new method of identifying drugs to treat children suffering from fatal cancers for which an effective treatment has not been found. Rather than developing a new drug from scratch, which is a complicated and time-consuming process, they tried a different approach.
June 23, 2010
Cancer Therapy Goes Viral: Progress Is Made Tackling Tumors with Viruses
We are excited to share an article from the June issue of Scientific American that prominently features JX-594, a virus that has shown strong preclinical evidence in neuroblastoma and sarcomas. SKC in partnership with two renowned children's cancer hospitals and Jennerex Biotherapeutics is introducing the first clinical trial using an oncolytic virus for children with cancer in the U.S. in the next few months.
May 13, 2010
What a Night at the Museum!
Our Spring Celebration on May 12th was a fabulous success! We thank everyone who supported Solving Kids' Cancer's First Spring Celebration which was held at the American Museum of Natural History. The event raised more than $400,000. For exciting photos and more visit our SKC Events section of our website.
February 25, 2010
SKC Bridges the Gap for Innovative Researcher in 2010
A promising clinical trial for pediatric solid tumors is delayed by bureaucracy. Solving Kids' Cancer steps in.
September 23, 2009
New Protein Partnership That Leads To Pediatric Tumor Regression
Why are some pediatric cancers able to spontaneously regress? Prof. Michael Fainzilber and his team of the Weizmann Institute’s Biological Chemistry Department seem to have unexpectedly found part of the answer. Further research towards a better understanding of the mechanism of action might hopefully lead, in the future, to the development of drugs that will be able to induce regression of certain tumors.
August 20, 2009
Long-term Health And Social Outcomes For Neuroblastoma Survivors
Survivors of the childhood cancer neuroblastoma are eight times more likely to have chronic health conditions, less likely to be married, and more likely to have lower incomes than their siblings, according to a study published online July 31 in the Journal of the National Cancer Institute. This study was undertaken because minimal information exists on the long-term outcomes for neuroblastoma survivors.
May 01, 2009
SKC Partners To Launch Innovative Experimental Trial For Children With Solid Tumors
Solving Kids’ Cancer partners with another like-minded charity (Magic Water) to launch an innovative pilot study for children’s cancer. In partnership with the University of Wisconsin, the pilot study was launched in May, 2009 with the goal to treat 10-12 children in order to determine whether this approach is effective in achieving clinical responses, and hopefully cures, for children who have failed conventional therapies.
Events
May 07, 2013
2013 Spring Celebration Gala
SKC's annual Spring Celebration, held on Tuesday, May 7th at 583 Park, was a truly memorable evening. We raised over $440,000 to develop less toxic and more effective therapies for children with the deadliest childhood cancers.
December 12, 2012
MIT Sloan MBA Auction & Dinner
MBA students from MIT Sloan class of 2014 raise $8500 in auction event!!
September 09, 2012
A NIGHT WITH IKE DAVIS
What a Night it was!! Host and Mets first baseman Ike Davis was joined by 13 teammates who stepped behind the bar and served up libations. Add to that the diverse artistry of country music singer Lee Brice and everyone had an experience of a lifetime!
June 19, 2012
Solving Kids' Cancer Junior Board Summer Games
The Junior Board of Solving Kids' Cancer hosted an evening of serious summer fun at Greenwich Village Country Club! This dynamic group of young professionals entertained guests with fun and competitive Wii games, rounds of mini golf, Foosball, and shuffleboard, all for the ultimate Summer Games experience.
May 09, 2012
Third Annual Spring Celebration
Solving Kids' Cancer held the Third Annual Spring Celebration on Wednesday, May 9, 2012 at Gotham Hall in Manhattan. The evening was a celebration of children and the renewal of spring.
April 17, 2012
Team Hazen - LA Half-Marathon
If it weren't for cancer, on January 14th, Hazen would have been eleven years old. To celebrate his birthday, friends publicly declared that they will run the Hollywood Half Marathon as TEAM HAZEN in his honor. Hazen always wanted to run a marathon. Now he is, thanks to your support.
September 12, 2011
BGC Charity Day 2011
Solving Kids' Cancer was honored to be invited to participate in the Seventh Annual BGC Worldwide Charity Day on Monday, September 12th.
Podcasts“This Week in Pediatric Oncology”
May 07, 2012
TWiPO #26 ~ Killer Immunoglobulin Receptor (KIR) Mismatch in Neuroblastoma
April 05, 2012
TWiPO #25 ~ Histones in Pediatric Gliomas
March 06, 2012
TWiPO #24 ~ Cord Blood Banking: Interview with Machi Scaradavou
January 26, 2012
TWiPO #23 ~ Neuroblastoma Jeopardy 2011
December 05, 2011
TWiPO #22 ~ Brain Tumor Year-End Round Robin
November 29, 2011
TWiPO #21 ~ Interview with Dr. Beatrice Lampkin
November 15, 2011
TWiPO #20 ~ The F-word in Pediatric Cancer Research
October 30, 2011
TWiPO #19 ~ More on Hedgehog signaling, brain tumor risk from cell phone use, and FDA approval of cancer drugs
October 18, 2011
TWiPO #18 ~ Targeting EWS-FLI1 in Ewing's Sarcoma: Interview with Dr Jeff Toretsky
October 13, 2011
TWiPO #17 ~ Personalized medicine: Interview with Dr Giselle Sholler
October 07, 2011
TWiPO #16 ~ Genetic Underpinnings of Ewing Sarcoma: Interview with Dr Stephen L. Lessnick
September 28, 2011
TWiPO #15 ~ MicroRNAs and hereditary cancer
August 24, 2011
TWiPO #14 ~ Interview with Dr Kate Matthay
August 19, 2011
TWiPO #13 ~ Updates, epidemiology of CNS tumors, birth order, and cell phone risks
August 05, 2011
TWiPO #12 ~ ALL: Anti-CD19 BiTE and Genetic Risk Groups
July 12, 2011
TWiPO #11 ~ BuMel SIOP results and MIBG transplant with Dr Brian Weiss
July 07, 2011
TWiPO #10 ~ Interview with Dr Robert Seeger
June 16, 2011
TWiPO #9 ~ Interview with Dr Peter Adamson
June 09, 2011
TWiPO #8 ~ Seneca Valley virus and medulloblastoma
June 02, 2011
TWiPO #7 ~ Interview with E. Anders Kolb and Andrew Napper on drug development
May 26, 2011
TWiPO #6 ~ Interview with Dr Archie Bleyer
May 19, 2011
TWiPO #5 ~ Hedgehog Signaling and Itraconazole
May 08, 2011
TWiPO #4 ~ Meetings Recap and Immunotherapy for Synovial Cell Sarcoma
April 25, 2011
TWiPO #3 ~ Vincristine Pharmacogenetics, Irinotecan/Temozolomide for Relapsed Neuroblastoma
April 13, 2011
TWiPO #2 ~ Interview with Greg Reaman
April 11, 2011
TWiPO #1 ~ Epidemiology of Childhood Cancer
Register for updates
Become a Fan of SKC
Therapeutic ideas are reviewed with priority on a rolling basis